Dergiler / İstanbul Kuzey Klinikleri / 2017 / Cilt: 4 - Sayı: 3

Lipid profile and plasma atherogenic index in postmenopausal osteoporosis

Sayfa
237–241
Yayın Tarihi
2022-10-18
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The level of significance wasaccepted as p

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:OBJECTIVE: The goal of this study was to investigate the relationship between the lipid profile, plasma atherogenicindex (PAI), and osteoporosis in postmenopausal women.METHODS: The data of age, duration of menopause, height, weight, lipid profile, bone mineral density (BMD)value, and history of oral contraceptive use of 407 postmenopausal women who had not been menstruatingfor at least 12 months, were between the ages 45 and 80, and presented at the obstetrics and gynecologypolyclinic of Kartal Dr.
📊
Temel Bulgular & Veri:The patients were dividedinto 2 groups according to the presence of osteoporosis, and the data compared.
💡
Sonuç & Katkı:The level of significance wasaccepted as p
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

OBJECTIVE: The goal of this study was to investigate the relationship between the lipid profile, plasma atherogenicindex (PAI), and osteoporosis in postmenopausal women.METHODS: The data of age, duration of menopause, height, weight, lipid profile, bone mineral density (BMD)value, and history of oral contraceptive use of 407 postmenopausal women who had not been menstruatingfor at least 12 months, were between the ages 45 and 80, and presented at the obstetrics and gynecologypolyclinic of Kartal Dr. Lutfi Kirdar Training and Research Hospital were reviewed. The patients were dividedinto 2 groups according to the presence of osteoporosis, and the data compared. The level of significance wasaccepted as p

🔖

Bu Makaleye Atıf Yap

SİMSEK, E. E., VATANSEVER, D., KASIKCI, H. O., ERSOY, G. S., SAKİN, O., KESER, B. (2022). Lipid profile and plasma atherogenic index in postmenopausal osteoporosis. İstanbul Kuzey Klinikleri, Cilt: 4 - Sayı: 3, 237–241. https://ajindex.com/articles/551587

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Kenny AM, Prestwood KM. Osteoporosis, pathogenesis, diagnosis and treatment in older adults. Rheum Dis Clin N Am 2000;26:569–91
  2. Lindsay R. Sex steroids in the pathogenesis and prevention of osteoporosis. In: Riggs BL, Melton LJ, ed. 1988 Osteoporosis: etiology, diagnosis, and management. New York: Raven Press; p.333–58
  3. Bolzetta F, Veronese N, De Rui M, Berton L, Carraro S, Pizzato S, et al. Duration of breastfeeding as a risk factor for vertebral fractures. Bone 2014;68:41–5
  4. Sahin Ersoy G, Giray B, Subas S, Simsek E, Sakin O, Turhan OT, et al. Interpregnancy interval as a risk factor for postmenopausal osteoporosis. Maturitas 2015;82:236–40
  5. Tintut Y, Morony S, Demer LL. Hyperlipidemia promotes osteoclastic potential of bone marrow cells ex vivo. Arterioscler Thromb Biol 2004;24:6–10. 240 North Clin Istanb 6. Parhami F, Garfinkel A, Demer LL. Role of lipids in osteoporosis. Arterioscler Thromb Vasc Biol 2000;20:2346–8
  6. Tanko LB, Christiansen C, Cox DA, Geiger MJ, McNabb MA, Cummings SR. Relationship between osteoporosis and cardiovascular disease in postmenopausal women. J Bone Miner Res 2005;20:1912–20
  7. Buizert PJ, van Schoor NM, Lips P, Deeg DJ, Eekhoff EM. Lipid levels: a link between cardiovascular disease and osteoporosis? J Bone Miner Res 2009;24:1103–9
  8. Dobiásová M, Frohlich J. The plasma parameter log (TG/ HDLC) as an atherogenic index: Correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma [FER (HDL)]. Clin Biochem 2001;34:583–8
  9. Rolland-Cachera MF, Cole TJ, Sempe M. Body mass index variations: centiles from birth to 87 years. Eur J Clin Nutr 1991;45:13–21
  10. Link TM, Majumdar S. Osteoporosis imaging. Radio Clin N Am 2003;41:813-839
  11. Ramos RG, Olden K. The prevalence of metabolic syndrome among US women of childbearing age. Am J Public Health 2008;98:1122–7
  12. Davis CE, Pajak A, Rywik S, Williams DH, Broda G, Pazucha T, et al. Natural menopause and cardiovascular disease risk factors. The Poland and US Collaborative Study on Cardiovascular Disease Epidemiology. Ann Epidemiol 1994;4:445–8
  13. Brown SA, Hutchinson R, Morrisett J, Boerwinkle E, Davis CE, Gotto AM Jr, et al. Plasma lipid, lipoprotein cholesterol, and apoprotein distributions in selected US communities. The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb 1993;13:1139–58
  14. Demirovic J, Sprafka JM, Folsom AR, Laitinen D, Blackburn H. Menopause and serum cholesterol: difference